SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Arrowhead Pharmaceuticals Q2 EPS $(0.200) Misses $(0.110) Estimate, Sales $23.528M Beat $21.740M Estimate

Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported quarterly losses of $(0.200) per share which missed the analyst consensus estimate of $(0.110) by 81.82 percent. This is a 183.33 percent decrease over earnings of $0.240

Benzinga · 05/07/2020 20:01

Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported quarterly losses of $(0.200) per share which missed the analyst consensus estimate of $(0.110) by 81.82 percent. This is a 183.33 percent decrease over earnings of $0.240 per share from the same period last year. The company reported quarterly sales of $23.528 million which beat the analyst consensus estimate of $21.740 million by 8.22 percent. This is a 51.13 percent decrease over sales of $48.148 million the same period last year.